AdVance™ XP

Established outcomes

• More than 10 years of clinical use.¹
• More than 30,000 patients treated.¹
• Demonstrated cured and improved rates ranging from 63.1% - 83.0% at 5 years in patients with mild to moderate incontinence. ^2.3
• In patients with higher BMIs, AdVance XP sling has higher cure and improved rates over AdVance Sling.⁴
  
• More than 65 articles published (on AdVance and AdVance XP) in scientific, peer-reviewed journals, reporting on the experience in more than 5,000 patients.¹
  
• No erosions or explantations of either a whole sling system or fragments of the sling were described throughout the (5 year) follow-up period.³
• Chronic urinary retention after AdVance Sling placement is uncommon and acute retention is generally self‐limiting.⁵
  
• ICIQ score improved from 14.9 at baseline to 5.0 at 5 years. IQoL improved from 67.3 at baseline to 96.8 at 5 years.³
  

Patient benefits

• Minimally invasive procedure designed to allow most patients to resume normal, daily activities 1 -2 weeks post procedure*
• Patients may be continent immediately following their procedure⁶
• Patient manual dexterity and mental acuity are not criteria for exclusion⁶
• Can be used in combination with inflatable penile prosthesis⁷
• If needed, the transition from an AdVance Sling to an AMS 800™ Artificial Urinary Sphincter does not usually require mesh excision⁸
• The Advance XP displays excellent continence results and secure effectiveness over a 5-year period.³ Data also demonstrated a low complication rate and improved quality of life in the long-term use of AdVance XP.³
  

*per physician's discretion